EMA Application withdrawn: Lunivia (eszopiclone) — Sepracor Ltd.

View source ↗

Summary

The EMA has withdrawn the application for Lunivia (eszopiclone) by Sepracor Ltd. for sleep initiation and maintenance disorders.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sleep Initiation Disorders
• Sleep Maintenance Disorders

Drugs mentioned

• Lunivia (eszopiclone)

Snippet

Status: Application withdrawn. Therapeutic area: Sleep Initiation and Maintenance Disorders. MAH: Sepracor Ltd.. Decision date: 15/05/2009